SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-103212
Filing Date
2023-09-22
Accepted
2023-09-22 16:30:43
Documents
12
Period of Report
2023-09-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326758d1_8k.htm   iXBRL 8-K 30665
  Complete submission text file 0001104659-23-103212.txt   205050

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ampe-20230918.xsd EX-101.SCH 3024
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20230918_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20230918_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2326758d1_8k_htm.xml XML 3319
Mailing Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112
Business Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 231272110
SIC: 2834 Pharmaceutical Preparations